Cyclosporine A (CsA)

DRUG9 trials

Conditions

Acute Lymphoblastic Leukemia, High RiskAcute Lymphoblastic Leukemia, RelapseAcute Lymphocytic LeukemiaAcute Myelogenous LeukemiaAcute Myeloid Leukemia, High RiskAcute Myeloid Leukemia, RelapsedAtopic DermatitisChronic Lymphocytic Leukemia

Phase 1

Immune Tolerance Study With Aldurazyme® (Laronidase)

CompletedNCT00741338

Genzyme, a Sanofi CompanyMucopolysaccharidosis I

Start: 2008-09-30End: 2012-09-30Updated: 2014-07-02

Phase 2

Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant

CompletedNCT00571662

University of NebraskaAcute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Chronic Lymphocytic Leukemia +6

Start: 2000-12-08End: 2008-12-30Updated: 2023-10-24

Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Myelodysplastic Syndromes

NCT01129739

Shandong UniversityMyelodysplastic Syndromes

Start: 2010-05-31End: 2013-05-31Target: 30Updated: 2010-05-25

Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia

CompletedNCT04328727

Novartis PharmaceuticalsSevere Aplastic Anemia (SAA)

Start: 2020-11-04End: 2024-12-06Updated: 2026-01-13

Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies

RecruitingNCT07366801

Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyAcute Lymphoblastic Leukemia, High Risk, Acute Lymphoblastic Leukemia, Relapse, Acute Myeloid Leukemia, High Risk +1

Start: 2025-09-03End: 2028-02-03Target: 64Updated: 2026-01-26

Phase 3

Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients

CompletedNCT00251004

NovartisGraft Rejection, Kidney Transplantation

Start: 2005-10-31End: 2009-10-31Updated: 2011-05-10

A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Heart Transplant Patients.

CompletedNCT02091414

Hoffmann-La RocheHeart Transplantation

Start: 2006-08-31End: 2009-02-28Updated: 2014-10-29

A Study of Romiplostim N01 Plus IST vs. Placebo Plus IST for Treatment-Naive Severe Aplastic Anemia

Not yet recruitingNCT07345000

Qilu Pharmaceutical Co., Ltd.Treatment-naïve Severe Aplastic Anemia

Start: 2026-01-31End: 2030-08-31Target: 210Updated: 2026-01-15

Unknown Phase

Photophoresis Versus Ciclosporine in Severe Atopic Dermatitis

CompletedNCT02226068

University of AarhusAtopic Dermatitis

Start: 2002-06-30End: 2004-01-31Updated: 2015-03-27

Related Papers

Immune tolerance induction for laronidase treatment in mucopolysaccharidosis I.

2017-01-1312 citations